2.New Step of Joint Publication with the Korean Association for Clinical Oncology.
Cancer Research and Treatment 2012;44(2):73-73
No abstract available.
Joints
;
Medical Oncology
;
Publications
3.New achievements of molecular biology in oncology
Journal of Medical and Pharmaceutical Information 2000;(4):7-10
During transition years of 20th and 21st century, the molecular biology has had major progresses in the finding the nature of cancer's generation, early detection, prognosis and treatment of cancer. The molecular techniques were important breakthrough. The predominant achievement was to newly discover the role of telomere, telomerase and surviving in the cancer.
Molecular Biology
;
Medical Oncology
10.The 150 most important questions in cancer research and clinical oncology series: questions 86-93 : Edited by Chinese Journal of Cancer.
Chinese Journal of Cancer 2018;37(1):1-1
Since the beginning of 2017, Chinese Journal of Cancer has published a series of important questions in cancer research and clinical oncology, which spark diverse thoughts, interesting communications, and potential collaborations among researchers all over the world. In this article, 8 more questions are presented as follows. Question 86. In which circumstances is good supportive care associated with a survival advantage in patients with cancer? Question 87. Can we develop animal models to mimic immunotherapy response of cancer patients? Question 88. What are the mechanisms underlying hepatitis B virus-associated non-hepatocellular cancers? Question 89. Can we more precisely target tumor metabolism by identifying individual patients who would benefit from the treatment? Question 90. What type of cranial irradiation-based prophylactic therapy combination can dramatically improve the survival of patients with extensive small-cell lung cancer? Question 91. How can postoperative radiotherapy prolong overall survival of the patients with resected pIIIA-N2 non-small cell lung cancer? Question 92. What are the key molecular events that drive oral leukoplakia or erythroplakia into oral cancer? Question 93. How could we track the chemotherapeutics-driven evolution of tumor genome in non-small cell lung cancer for more effective treatment?
Humans
;
Medical Oncology
;
education
;
Neoplasms
;
genetics
;
Research
Result Analysis
Print
Save
E-mail